Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Mechoulam

Showing results (51-60 of 183) with videos related to

Pageof 19
Sort By:
Journal of Basic and Clinical Physiology and Pharmacology|November 14, 2015
Are the endocannabinoid-like compounds N-acyl aminoacids neuroprotective after traumatic brain injury?Aniv Mann, Ayelet Cohen-Yeshurun, Victoria Trembovler, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 25, 2005
CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibitionDavid Panikashvili, Raphael Mechoulam, Sara M Beni, et al.
Frontiers in Medicine|February 28, 2022
Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective StudyLihi Bar-Lev Schleider, Raphael Mechoulam, Inbal Sikorin, et al.
The European Journal of Neuroscience|August 4, 2007
Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptorsOnintza Sagredo, José A Ramos, Alessandra Decio, et al.
Psychopharmacology|May 13, 2004
Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in ratsLinda A Parker, Page Burton, Robert E Sorge, et al.
Annals of the New York Academy of Sciences|January 10, 2015
CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinolElad Wasserman, Joseph Tam, Raphael Mechoulam, et al.
Molecular Pharmacology|October 30, 2007
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2Douglas McHugh, Carolyn Tanner, Raphael Mechoulam, et al.
Scientific Reports|January 19, 2019
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and EfficacyLihi Bar-Lev Schleider, Raphael Mechoulam, Naama Saban, et al.
Neuropharmacology|May 25, 2005
Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferensRoger G Pertwee, Adèle Thomas, Lesley A Stevenson, et al.
Trends in Pharmacological Sciences|September 5, 2009
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herbAngelo A Izzo, Francesca Borrelli, Raffaele Capasso, et al.
Pageof 19

Showing results (51-60 of 183) with videos related to

Sort By:
Pageof 19
Journal of Basic and Clinical Physiology and Pharmacology|November 14, 2015
Are the endocannabinoid-like compounds N-acyl aminoacids neuroprotective after traumatic brain injury?Aniv Mann, Ayelet Cohen-Yeshurun, Victoria Trembovler, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|February 25, 2005
CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibitionDavid Panikashvili, Raphael Mechoulam, Sara M Beni, et al.
Frontiers in Medicine|February 28, 2022
Adherence, Safety, and Effectiveness of Medical Cannabis and Epidemiological Characteristics of the Patient Population: A Prospective StudyLihi Bar-Lev Schleider, Raphael Mechoulam, Inbal Sikorin, et al.
The European Journal of Neuroscience|August 4, 2007
Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptorsOnintza Sagredo, José A Ramos, Alessandra Decio, et al.
Psychopharmacology|May 13, 2004
Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in ratsLinda A Parker, Page Burton, Robert E Sorge, et al.
Annals of the New York Academy of Sciences|January 10, 2015
CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinolElad Wasserman, Joseph Tam, Raphael Mechoulam, et al.
Molecular Pharmacology|October 30, 2007
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2Douglas McHugh, Carolyn Tanner, Raphael Mechoulam, et al.
Scientific Reports|January 19, 2019
Real life Experience of Medical Cannabis Treatment in Autism: Analysis of Safety and EfficacyLihi Bar-Lev Schleider, Raphael Mechoulam, Naama Saban, et al.
Neuropharmacology|May 25, 2005
Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferensRoger G Pertwee, Adèle Thomas, Lesley A Stevenson, et al.
Trends in Pharmacological Sciences|September 5, 2009
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herbAngelo A Izzo, Francesca Borrelli, Raffaele Capasso, et al.
Pageof 19